Outcomes of random start versus clomiphene citrate and gonadotropin cycles in occult premature ovarian insufficiency patients, refusing oocyte donation: a retrospective cohort study

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
Safak HatirnazMichael H Dahan

Abstract

The aim of this study is to present the clinical outcomes of a random start, a spontaneous folliculogenesis protocol versus Clomiphene Citrate and Gonadotropin treatment in women with occult premature ovarian insufficiency. Women underwent treatment between 1 February 2009, and 30 May 2016. 41 women were treated with the random start protocol while 48 cases received ovarian stimulation with clomiphene and gonadotropins. All included cases met the criteria of 4 months of oligo-ovulation, follicular-stimulating hormone levels over 30 IU/L and anti-Mullerian hormone levels below 0.30 ng/mL. The random start protocol involved following the subjects for up to 6 months until spontaneous folliculogenesis occurred. The mean number of oocytes collected, mature oocytes, fertilized oocytes, and grade II embryos were significantly higher in the random start protocol (p < .05). The doses of gonadotropin administration and hCG were significantly lower in the random start protocol (p < .05). The clinical pregnancy and live birth rates were significantly higher in the random start protocol (p < .05). Likely stimulation is of little benefit in women with occult premature ovarian insufficiency. Observation while waiting for spontaneous folliculo...Continue Reading

References

Jul 16, 1999·Seminars in Reproductive Endocrinology·H Fleming
Oct 30, 2003·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Bhaumik PatelVed V Gossain
Mar 4, 2008·Journal of Pediatric and Adolescent Gynecology·Melissa CameronYasmin Jayasinghe
Oct 16, 2008·Reproductive Biomedicine Online·Ezgi DemirtasSeang Lin Tan
Sep 16, 2009·Human Reproduction Update·A L ChandA N Shelling
Apr 13, 2010·Reproductive Biomedicine Online·Hridesh DixitLalji Singh
Apr 29, 2010·Menopause International·Kate MaclaranNick Panay
May 5, 2010·Reproductive Sciences·Paulo Homem de Mello BianchiEdmund Chada Baracat
May 27, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Arif Kokcu
Aug 19, 2010·Reproduction : the Official Journal of the Society for the Study of Fertility·Andrew N Shelling
Sep 17, 2010·Seminars in Reproductive Medicine·Pinar H Kodaman
Dec 29, 2010·Archives of Gynecology and Obstetrics·Emerson Barchi CordtsCaio Parente Barbosa
Mar 4, 2011·The Journal of Family Planning and Reproductive Health Care·Kate Maclaran, Nick Panay
Jul 13, 2011·Molecular and Cellular Endocrinology·Brianna Cloke, Mark Christian
Nov 10, 2011·Human Reproduction Update·Angela R BaerwaldRoger A Pierson
Dec 27, 2011·Molecular and Cellular Endocrinology·Heng-Yu FanJoAnne S Richards
Feb 4, 2012·Maturitas·Konstantinos Michalakis, Simon W Coppack
Aug 31, 2012·Science China. Life Sciences·Qian LiQingHua Shi
Aug 31, 2012·Science China. Life Sciences·Min JinHeFeng Huang
Jun 28, 2014·Australian Orthodontic Journal·Craig Dreyer
Oct 16, 2014·Journal of the Turkish German Gynecological Association·Yavuz Emre SükürBatuhan Ozmen
Feb 16, 2015·Obstetrics and Gynecology Clinics of North America·Ertug Kovanci, Amy K Schutt
Jul 26, 2015·Reproductive Biology and Endocrinology : RB&E·John Zhang

❮ Previous
Next ❯

Citations

Jul 18, 2019·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Svetlana Dragojević DikićSvetlana Vujović

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved